Reporting owner · CIK 0001836218
Rodino-Klapac Louise
Visual SEC Form 4 history across 1 companies, 7 transactions and 4 filings.
PRES, R, DTOPresident, R&D and Tech OpsSarepta Therapeutics, Inc.
Open-market mix
—buys
Open-market buy performance
90-day forward return on this insider's open-market purchases
Forward return is not available yet
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Buys Sells
No open-market purchases or sales in this history.
Net value flow
Buys minus sells
Feb 25
$0
Mar 25
$0
Sep 26
$0
Transaction texture
Ownership and ticket size
Average P/S size—
Median P/S size—
Direct7
Indirect0
Sep 04, 2026withholding
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
Latest transaction
No latest transaction fact is available.
Latest buy
No open-market insider purchase is available.
Latest sale
No open-market insider sale is available.
Associated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| SRPT | Rodino-Klapac Louise | PRESRDTO | withholding | 21.4k | -$47.6M | F | 0.0% | 09/09 | 09/04 | |
| SRPT | Rodino-Klapac Louise | HRDCSO | exercise | 17.5k | $0 | M | — | 03/11/2025 | 03/06/2025 | |
| SRPT | Rodino-Klapac Louise | HRDCSO | withholding | 7.99k | -$82.8M | F | — | 03/11/2025 | 03/07/2025 | |
| SRPT | Rodino-Klapac Louise | HRDCSO | withholding | 514 | -$5.33M | F | — | 03/11/2025 | 03/07/2025 | |
| SRPT | Rodino-Klapac Louise | HRDCSO | exercise | 17.5k | — | M | — | 03/11/2025 | 03/06/2025 | |
| SRPT | Rodino-Klapac Louise | HRDCSO | withholding | 715 | -$7.41M | F | — | 03/05/2025 | 03/03/2025 | |
| SRPT | Rodino-Klapac Louise | HRDCSO | grant | 3.50k | $0 | A | — | 02/14/2025 | 02/11/2025 |
Rodino-Klapac Louise Insider Activity FAQ
SEC Form 4 context
Who is Rodino-Klapac Louise?
Rodino-Klapac Louise is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001836218.
Which companies has Rodino-Klapac Louise reported transactions for?
Sarepta Therapeutics, Inc.
When was Rodino-Klapac Louise's latest insider buy?
No open-market insider purchase is available for this period.
When was Rodino-Klapac Louise's latest insider sale?
No open-market insider sale is available for this period.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.